Review
Copyright ©The Author(s) 2021.
World J Cardiol. Aug 26, 2021; 13(8): 271-297
Published online Aug 26, 2021. doi: 10.4330/wjc.v13.i8.271
Table 5 Main echo findings of cardiovascular pathologies in athletes
Pathology
What to assess? (echo view)
Cut-off mm (mean mm)
If pathological, what to assess? (echo view)
Cut-off mm (mean mm)
HCMLV Max end-diastolic wall thicknessM white 15 (10); M Afro-American 16 (11.5); F white 11; F Afro-American 13 (9.5); M/F adolescent 16 (12)LV wall thickness distributionAsymmetric (HCM)
LV end diastolic diameter (A4C)M 70 (55); F 66 (49); Adolescent 60 (51)
LV mass/BSAM 117 mm/m2 (83 mm/m2); F 143 mm/m2 (101 mm/m2)
LVOT obstruction
E/A (A4C)1.3 (1.93)
DCMLV end diastolic diameter (PLAX)M 70 (50); F 66 (49); Adolescent 60 (51)EF (A4C)55% (64%)
LVNCLV trabeculationNC/C layer ratio > 2.0 in systoleEF (A4C)55% (64%)
Thickness of compact layer in systole8
E/A (A4C)1.3 (1.93)
ARVCRVOT/BSA (PSAX)> 21 mm/m2RV inflow (A4C)/ LV end diastolic diameter (PLAX)> 0.9
RVOVT/BSA (PLAX)> 19 mm/m2RV wall motion abnormalities
RV FAC33%
Aortic dilatation Aortic valve max dimension (PLAX)M 40 (32); F 34 (28)Other congenital defects (BAV)
Ascending aorta dimension (PLAX)Aortic regurgitation
Mitral prolapse Mitral prolapse (PLAX)Abnormal systolic bulging of leaflets > 2 mm toward LA Mitral regurgitation
PAPS (A4C)40 mmHg (24 mmHg)
Pulmonary veins flow Reverse
EF (A4C)55% (64%)
LV mass/BSAM 117 mm/m2 (83 mm/m2); F 143 mm/m2 (101 mm/m2)
LAVI M 36 mm/m2 (28 mm/m2); F 33 mm/m2 (26.5 mm/m2)
AOCACoronary arteries origin (PSAX)
BAVAortic morphology (PSAX)Aortic stenosis
Aortic regurgitation
Aortic root max dimension (PLAX)M 40 (32); F 34 (28)
Other congenital defects (coarctation of the aorta, interrupted aortic arch, patent ductus arteriosus, coronary anomaly or hypoplastic left heart, as well as Williams or Turner syndrome)
ASDASDRV dimension (A4C)Basal RV: M 55 (43.5), F 49 (39); Medial RV: M 47 (34), F 43 (32); Longitudinal RV: M 109 (89), F 100 (82)
RA area/BSA (A4C)M 28 mm/m2 (19.5 mm/m2); F 24 mm/m2 (15.5 mm/m2)
PAPS (A4C)40 mmHg (24 mmHg)
VSDVSDLV mass/BSA (PLAX)M 117 mm/m2 (83 mm/m2); F 143 mm/m2 (101 mm/m2)
PAPS (A4C)40 mmHg (24 mmHg)
Aortic regurgitation
Other congenital defects (aneurysm of Valsalva sinus, ToF, TGA, DCRV)
PDAPDA (PSAX)LA/Aortic root ratio≥ 1.4
LV mass/BSA (PLAX)M 117 mm/m2 (83 mm/m2); F 143 mm/m2 (101 mm/m2)
PAPS (A4C)40 mmHg (24 mmHg)
Pulmonary artery size (PSAX)
RV dimension (A4C)Basal RV: M 55 (43.5), F 49 (39); Medial RV: M 47 (34), F 43 (32); Longitudinal RV: M 109 (89), F 100 (82)
RA area/BSA (A4C)M 28 mm/m2 (19.5 mm/m2); F 24 mm/m2 (15.5 mm/m2)
Other congenital defects (COA, pulmonary atresia)
COACOA (PSAX)Aortic stenosis
Mitral stenosis
LV mass/BSA (PSAX)M 117 mm/m2 (83 mm/m2); F 143 mm/m2 (101 mm/m2)
EF (A4C)55% (64%)
Other congenital defects (BAV, ascending aortic aneurysm)
MyocarditisEF (A4C)55% (64%)
LV wall motion abnormalities
Pericardial effusion
Increased LV wall thickness
PericarditisPericardial effusion
Kawasaki diseaseCoronary artery abnormalities
EF (A4C)55% (64%)
LV wall motion abnormalities
Mitral regurgitation
Aortic regurgitation
Pericardial effusion